852 related articles for article (PubMed ID: 12218214)
41. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
Ronnett BM; Seidman JD
Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
[TBL] [Abstract][Full Text] [Related]
42. Pseudomyxoma peritonei. Histologic predictors of patient survival.
Costa MJ
Arch Pathol Lab Med; 1994 Dec; 118(12):1215-9. PubMed ID: 7979917
[TBL] [Abstract][Full Text] [Related]
43. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
[TBL] [Abstract][Full Text] [Related]
44. Pseudomyxoma peritonei associated with ovarian mucinous tumors. Cytologic appearance in five cases.
Leiman G; Goldberg R
Acta Cytol; 1992; 36(3):299-304. PubMed ID: 1316027
[TBL] [Abstract][Full Text] [Related]
45. Unusual tumors of the appendix and pseudomyxoma peritonei.
Carr NJ; Sobin LH
Semin Diagn Pathol; 1996 Nov; 13(4):314-25. PubMed ID: 8946609
[TBL] [Abstract][Full Text] [Related]
46. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.
Yajima N; Wada R; Yamagishi S; Mizukami H; Itabashi C; Yagihashi S
Hum Pathol; 2005 Nov; 36(11):1217-25. PubMed ID: 16260276
[TBL] [Abstract][Full Text] [Related]
48. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
Murphy EM; Sexton R; Moran BJ
Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
[TBL] [Abstract][Full Text] [Related]
49. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
50. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.
Flatmark K; Reed W; Halvorsen T; Sørensen O; Wiig JN; Larsen SG; Fodstad Ø; Giercksky KE
BMC Cancer; 2007 Jun; 7():116. PubMed ID: 17603904
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women.
Ronnett BM; Shmookler BM; Diener-West M; Sugarbaker PH; Kurman RJ
Int J Gynecol Pathol; 1997 Jan; 16(1):1-9. PubMed ID: 8986525
[TBL] [Abstract][Full Text] [Related]
52. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
Dong Y; Walsh MD; Cummings MC; Wright RG; Khoo SK; Parsons PG; McGuckin MA
J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
[TBL] [Abstract][Full Text] [Related]
53. Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.
Zoghbi S; Drouin E; Claustre J; Bara J; Scoazec JY; Plaisancié P
Int J Oncol; 2007 Feb; 30(2):489-97. PubMed ID: 17203232
[TBL] [Abstract][Full Text] [Related]
54. Borderline-like mucinous tumor arising in mature cystic teratoma of the ovary associated with pseudomyxoma peritonei.
Hwang JH; So KA; Modi G; Lee JK; Lee NW; Lee KW; Kim I
Int J Gynecol Pathol; 2009 Jul; 28(4):376-80. PubMed ID: 19483624
[TBL] [Abstract][Full Text] [Related]
55. Mucinous cystadenocarcinoma of the appendix. The controversy persists: a review.
Lo NS; Sarr MG
Hepatogastroenterology; 2003; 50(50):432-7. PubMed ID: 12749241
[TBL] [Abstract][Full Text] [Related]
56. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva.
McKenzie RW; Jumblatt JE; Jumblatt MM
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):703-8. PubMed ID: 10711684
[TBL] [Abstract][Full Text] [Related]
57. Mucinous cystadenocarcinoma arising in mature cystic teratoma ovary and associated pseudomyxoma peritonei: report of a case.
Mandal S; Kawatra V; Khurana N
Arch Gynecol Obstet; 2008 Sep; 278(3):265-7. PubMed ID: 18293005
[TBL] [Abstract][Full Text] [Related]
58. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
59. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG
Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402
[TBL] [Abstract][Full Text] [Related]
60. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.
Yan F; Lin Y; Zhou Q; Chang H; Li Y
Hum Pathol; 2020 Mar; 97():9-18. PubMed ID: 31926211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
